JAMDA
April 17, 2015
Showing 421 - 430 of 2769 results
JAMDA
June 13, 2024
Falls Prevention Using AI and Remote Surveillance in Nursing Homes
The older population of United States is growing, with more adults having complicated medical conditions being admitted into nursing facilities and assisted living facilities. With the COVID-19 pandemic, the biggest challenge has been falls prevention, with an increasing number of patients being placed in ...
Spotlight
August 23, 2023
Buprenorphine and Substance Use Disorder in PALTC
The statistics regarding substance use disorders are frightening. On a special AMDA On-The-Go podcast, Sabine von Preyss-Friedman, MD, FACP, CMD, said, “In 2022 alone, the U.S. saw 109,000 deaths from drug overdoses, and Washington state has seen a 20% increase.” The good news, she said, is that effective ...
Caring for the Ages
June 28, 2017
Education on Basics Results in Significant CAUTI Reduction, Cost Savings
JAMDA
February 23, 2017
Reduction of Catheter Associated Urinary Tract Infection (CAUTI) – Back to Basics
Caring for the Ages
October 23, 2021
Key Guidelines for Gradual Dosage Reductions of Psychotropic Medications
JAMDA
October 29, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Dementia Risk Reduction in Older Adults With Type 2 Diabetes: A Retrospective Cohort Study
To evaluate the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on dementia risk compared with dipeptidyl peptidase-4 inhibitors (DPP-4is) among older adults with type 2 diabetes (T2D).
JAMDA
November 28, 2018
Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia
A high anticholinergic burden (AB) is associated with the occurrence of behavioral and psychological symptoms (BPSDs), which are frequent in dementia.
JAMDA
February 26, 2019
A Quality Improvement Project Using PAINAD to Improve Pain Management and Opioid Reduction in Persons with Dementia
Caring for the Ages
September 24, 2020
Unsafe Discharges: Ethics, Risk Reduction, and Obligations, Part 2
